Diagnos Laboratorium Utama Stock Beneish M Score
| DGNS Stock | IDR 220.00 4.00 1.79% |
Diagnos |
At this time, Diagnos Laboratorium's M Score is inapplicable. The earnings manipulation may begin if Diagnos Laboratorium's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Diagnos Laboratorium executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Diagnos Laboratorium's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-4.84
Beneish M Score - Inapplicable
Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
About Diagnos Laboratorium Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Diagnos Laboratorium Utama's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Diagnos Laboratorium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Diagnos Laboratorium Utama based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Diagnos Stock
Diagnos Laboratorium financial ratios help investors to determine whether Diagnos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagnos with respect to the benefits of owning Diagnos Laboratorium security.